544445 — Asston Pharmaceuticals Share Price
Last trade - 00:00- IN₹1.03bn
- IN₹1.10bn
- IN₹250.39m
- 32
- 24
- 70
- 35
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.63 | ||
| Price to Tang. Book | 9.63 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.12 | ||
| EV to EBITDA | 17.88 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 46.43% | ||
| Return on Equity | 50.56% | ||
| Operating Margin | 24.36% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 80.34 | 101.36 | 65.38 | 155.86 | 250.39 | n/a | n/a | 32.87% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +22.37 | +842.27 | +24.78 | +228.06 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Asston Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. The Company is engaged in the business of manufacturing and marketing tablets, capsules, oral liquid, external preparations (ointment, cream, gel and lotion), and oral powder (sachet, dry syrup), and others. It also manufactures various pharmaceutical products for different marketers on a loan license or on a contract manufacturing basis. Its business is primarily conducted on a principle-to-principal basis with various marketers. It operates in supplying pharmaceutical products directly to distributors and pharmacies. Its tablets include Aceclofenac Tablets BP 100 mg; Albendazole Tablets USP 400 mg; B-complex Tablets, and more. Its capsules include Amoxicillin Capsules BP 250 / 500 mg; Ampicillin and Cloxacillin Capsules 500 mg; Ampicillin Capsules BP 250 / 500 mg, and others.
Directors
- Last Annual
- March 31st, 2025
- Last Interim
- January 1st, 1970
- Incorporated
- April 16th, 2019
- Public Since
- July 16th, 2025
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 8,512,360
- Address
- THANE, 400614
- Web
- https://asstonpharmaceuticals.com/
- Phone
- +91 2249731419
- Auditors
- Darshil Doshi & Co
Similar to 544445
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
As of Today at 10:23 UTC, shares in Asston Pharmaceuticals are trading at IN₹121.25. This share price information is delayed by 15 minutes.
Shares in Asston Pharmaceuticals last closed at IN₹121.25 and the price had moved by over the past 365 days. In terms of relative price strength the Asston Pharmaceuticals share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreAsston Pharmaceuticals does not currently pay a dividend.
Asston Pharmaceuticals does not currently pay a dividend.
Asston Pharmaceuticals does not currently pay a dividend.
To buy shares in Asston Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹121.25, shares in Asston Pharmaceuticals had a market capitalisation of IN₹1.03bn.
Here are the trading details for Asston Pharmaceuticals:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 544445
Based on an overall assessment of its quality, value and momentum Asston Pharmaceuticals is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Asston Pharmaceuticals. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹121.25, shares in Asston Pharmaceuticals were trading +2.61% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Asston Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹121.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Asston Pharmaceuticals' directors